Breaking News Instant updates and real-time market news.

DRRX

Durect

$0.86

0.1336 (18.46%)

, GILD

Gilead

$64.87

-0.17 (-0.26%)

11:05
07/22/19
07/22
11:05
07/22/19
11:05

Gilead pact offers validation to Durect technology, says H.C. Wainwright

After Durect (DRRX) announced the "positive surprise" that Gilead Sciences (GILD) has licensed exclusive worldwide rights to use the company's SABER technology for HIV and hepatitis B virus development, H.C. Wainwright analyst Ed Arce said he believes this collaboration provides "substantial validation" to the SABER platform. The deal economics also provide Durect with a cash runway and flexibility, said Arce, who thinks other SABER deals could be coming. He keeps a Buy rating and $3.50 price target on Durect shares.

DRRX

Durect

$0.86

0.1336 (18.46%)

GILD

Gilead

$64.87

-0.17 (-0.26%)

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

DRRX Durect
$0.86

0.1336 (18.46%)

GILD Gilead
$64.87

-0.17 (-0.26%)

07/15/19
JEFF
07/15/19
NO CHANGE
Target $95
JEFF
Buy
Gilead deal with Galapagos 'smart and financially savvy,' says Jefferies
Gilead Sciences (GILD) will significantly expand its pipeline in a "smart and financially savvy" expanded partnership deal with Galapagos (GLPG), Jefferies analyst Michael Yee tells investors in a research note. Gilead essentially gained options on everything in Galapagos' pipeline without having to acquire the company full out, says the analyst. He likes the deal and thinks shares of Gilead will move higher as the Street's outlook continues to improve. Yee keeps a Buy rating on Gilead with a $95 price target.
07/15/19
STFL
07/15/19
NO CHANGE
Target $188
STFL
Buy
Galapagos price target raised to $188 from $121 at Stifel
Stifel analyst Adam Walsh raised his price target on Galapagos (GLPG) to $188 from $121 after the company announced a 10-year global research and development collaboration with Gilead (GILD), calling the collaboration "a win-win to both companies." The deal, which he thinks will keep Gilead and likely other buyers from acquiring Galapagos in the next 10 years, gives the latter a deep cash position and support to expand and accelerate its research and clinical programs while it is able to maintain its "unique culture, R&D platform and proven leadership," according to Walsh, who keeps a Buy rating on Galapagos shares.
07/15/19
07/15/19
DOWNGRADE

Market Perform
Galapagos downgraded to Market Perform after Gilead deal at Raymond James
As previously reported, Raymond James analyst Dane Leone downgraded Galapagos (GLPG) to Market Perform from Strong Buy after the company and Gilead (GILD) announced a major expansion of the current collaboration agreement and partnership between the two companies. The analyst believes Galapagos' stock has now fully realized his price target by achieving his core investment thesis. He retains a positive viewpoint of Galapagos within the context of the relationship expansion with Gilead, but will be watching for how key 2020 value drivers develop over the course of the second half of 2019.
07/18/19
PIPR
07/18/19
NO CHANGE
Target $10
PIPR
Overweight
Spring Bank research agreement with NIAID 'smart,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes that Spring Bank (SBPH) entered into a research agreement with the National Institute of Allergy and Infectious Diseases, or NIAID, to study preclinical HBV antisense oligonucleotides. With the recent Arrowhead (ARWR) partnership with Janssen (JNJ), the analyst sees this as a "smart development program" building on Spring Bank's HBV expertise. Tenthoff also notes that Spring Bank is conducting the Phase IIb CATALYST 1 and 2 trials of 400mg inarigivir monotherapy/combination with Vemlidy in naive and suppressed HBV patients with preliminary data in the second quarter of 2020, while partner Gilead (GILD) is conducting a Phase II study of inarigivir plus Vemlidy in naive and suppressed HBV patients with initial data likely at AASLD in November. He reiterates an Overweight rating and $10 price target on Spring Bank's shares.

TODAY'S FREE FLY STORIES

01:50
09/17/19
09/17
01:50
09/17/19
01:50
General news
FX Update: The Australian dollar ebbed to an 11-day low »

FX Update: The Australian…

01:35
09/17/19
09/17
01:35
09/17/19
01:35
General news
FX Action: »

FX Action: The Dollar…

01:25
09/17/19
09/17
01:25
09/17/19
01:25
General news
FOMC outlook: »

FOMC outlook: the Fed…

01:25
09/17/19
09/17
01:25
09/17/19
01:25
General news
Asian Market Wrap: »

Asian Market Wrap:…

XLRN

Acceleron

$44.67

0.75 (1.71%)

22:05
09/16/19
09/16
22:05
09/16/19
22:05
Recommendations
Acceleron analyst commentary at Piper Jaffray »

Acceleron's ACE-083…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

PNRL

Paringa Resources

$2.28

-0.06 (-2.56%)

20:18
09/16/19
09/16
20:18
09/16/19
20:18
Hot Stocks
Paringa Resources names Jim Middleton as Executive Advisor »

Paringa Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBNC

Reliant Bancorp

$24.70

0.16 (0.65%)

20:17
09/16/19
09/16
20:17
09/16/19
20:17
Hot Stocks
Reliant Bancorp to buy Tennessee Community Bank Holdings for $37.2M »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

ORCL

Oracle

$53.12

-0.64 (-1.19%)

, INTC

Intel

$52.21

-0.32 (-0.61%)

19:12
09/16/19
09/16
19:12
09/16/19
19:12
Hot Stocks
Intel, Oracle collaborate on Optane DC Persistent Memory »

Intel (INTC) and Oracle…

ORCL

Oracle

$53.12

-0.64 (-1.19%)

INTC

Intel

$52.21

-0.32 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ORCL

Oracle

$53.12

-0.64 (-1.19%)

, VMW

VMware

$155.87

4.81 (3.18%)

19:08
09/16/19
09/16
19:08
09/16/19
19:08
Hot Stocks
VMware, Oracle expand partnership on hybrid cloud »

Oracle (ORCL) and VMware…

ORCL

Oracle

$53.12

-0.64 (-1.19%)

VMW

VMware

$155.87

4.81 (3.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

, BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

19:05
09/16/19
09/16
19:05
09/16/19
19:05
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Aclaris…

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

GLW

Corning

$30.04

-0.12 (-0.40%)

XLRN

Acceleron

$44.67

0.75 (1.71%)

SHOP

Shopify

$337.93

-0.77 (-0.23%)

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

PSTV

Plus Therapeutics

$9.51

-0.05 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 18

    Sep

  • 01

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

  • 17

    Sep

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

19:03
09/16/19
09/16
19:03
09/16/19
19:03
Hot Stocks
3G Capital sells 25.1M shares of Kraft Heinz »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

18:53
09/16/19
09/16
18:53
09/16/19
18:53
Hot Stocks
Kraft Heinz's Lemann acquires nearly 3.5M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

HMSY

HMS Holdings

$37.14

0.24 (0.65%)

18:43
09/16/19
09/16
18:43
09/16/19
18:43
Hot Stocks
HMS Holdings acquires VitreosHealth for approximately $36.5M »

HMS Holdings announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:25
09/16/19
09/16
18:25
09/16/19
18:25
General news
U.S. industrial production preview: »

U.S. industrial…

18:25
09/16/19
09/16
18:25
09/16/19
18:25
General news
Treasury Market Summary »

Treasury Market Summary:…

ICAD

iCAD

$6.89

-0.01 (-0.14%)

18:25
09/16/19
09/16
18:25
09/16/19
18:25
Conference/Events
iCAD to hold an investor reception »

Management hosts "An…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 12

    Nov

GLW

Corning

$30.04

-0.12 (-0.40%)

18:18
09/16/19
09/16
18:18
09/16/19
18:18
Hot Stocks
Corning down 5.5% or $1.64 at $28.40 per share after cutting volume outlook »

As part of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

18:17
09/16/19
09/16
18:17
09/16/19
18:17
Periodicals
We Company IPO delayed until October at earliest, WSJ reports »

The We Company's IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$30.04

-0.12 (-0.40%)

18:16
09/16/19
09/16
18:16
09/16/19
18:16
Hot Stocks
Corning cuts Q3 volume guidance for Display and Optical Communications units »

Corning is providing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

18:05
09/16/19
09/16
18:05
09/16/19
18:05
Periodicals
Breaking Periodicals news story on We Company »

We Company IPO delayed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.21

-1.62 (-4.17%)

18:02
09/16/19
09/16
18:02
09/16/19
18:02
Periodicals
Auto workers strike could cost GM $100M daily, WSJ says »

General Motors could lose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLNE

Hamilton Lane

$59.95

-0.51 (-0.84%)

17:57
09/16/19
09/16
17:57
09/16/19
17:57
Hot Stocks
Hamilton Lane vice chairman sells 150K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

17:52
09/16/19
09/16
17:52
09/16/19
17:52
Conference/Events
SVB Leerink biotech analysts to hold analyst/industry conference call »

Biotech Analysts discuss…

HLNE

Hamilton Lane

$59.95

-0.51 (-0.84%)

17:52
09/16/19
09/16
17:52
09/16/19
17:52
Hot Stocks
Hamilton Lane chairman sells 78.5K shares of common »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GD

General Dynamics

$190.91

0.98 (0.52%)

, BAH

Booz Allen

$70.35

0.85 (1.22%)

17:44
09/16/19
09/16
17:44
09/16/19
17:44
Hot Stocks
General Dynamics, Booz Allen and Parsons awarded $427M max Air Force contract »

General Dynamics (GD),…

GD

General Dynamics

$190.91

0.98 (0.52%)

BAH

Booz Allen

$70.35

0.85 (1.22%)

PSN

Parsons

$37.25

0.35 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.